Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Cancer Research

• Publication date

  2017-05-15

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1158/0008-5472.CAN-16-3472PMID 28416491PMCID PMC5468752
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.

  2017cited by this paper
• Microbiota as a mediator of cancer progression and therapy

  2017cited by this paper
• Inflammatory networks underlying colorectal cancer

  2016cited by this paper
• Gut Microbiota, Inflammation, and Colorectal Cancer.

  2016cited by this paper
• Intrinsic Versus Extrinsic Cancer Risk Factors and Aging.

  2016cited by this paper
• Revised Estimates for the Number of Human and Bacteria Cells in the Body

  2016cited by this paper
• Fap2 Mediates Fusobacterium nucleatum Colorectal Adenocarcinoma Enrichment by Binding to Tumor-Expressed Gal-GalNAc.

  2016cited by this paper
• Cancer statistics, 2016

  2016cited by this paper
• Iron Homeostasis Regulates the Genotoxicity of Escherichia coli That Produces Colibactin

  2016cited by this paper
• Variation in cancer risk among tissues can be explained by the number of stem cell divisions

  2015cited by this paper
• Manipulation of the Gut Microbiota Reveals Role in Colon Tumorigenesis

  2015cited by this paper
• Role of colonic microbiota in colorectal carcinogenesis: a systematic review.

  2015cited by this paper
• Substantial contribution of extrinsic risk factors to cancer development

  2015cited by this paper
• Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment

  2015cited by this paper
• Cancers complicating inflammatory bowel disease.

  2015cited by this paper
• Exercise and the microbiota

  2015cited by this paper
• Mouse models of intestinal cancer

  2015cited by this paper
• T-cell Expression of IL10 Is Essential for Tumor Immune Surveillance in the Small Intestine

  2015cited by this paper
• Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack.

  2015cited by this paper
• Structure of the gut microbiome following colonization with human feces determines colonic tumor burden

  2014cited by this paper
• Bacterial genotoxin colibactin promotes colon tumour growth by inducing a senescence-associated secretory phenotype

  2014cited by this paper
• The Impact of Diet and Lifestyle on Gut Microbiota and Human Health

  2014cited by this paper
• Adenomatous polyps are driven by microbe-instigated focal inflammation and are controlled by IL-10-producing T cells.

  2013cited by this paper
• Colonization of the Human Gut by E. coli and Colorectal Cancer Risk

  2013cited by this paper
• The Gut Microbiome Modulates Colon Tumorigenesis

  2013cited by this paper
• Interplay between Siderophores and Colibactin Genotoxin Biosynthetic Pathways in Escherichia coli

  2013cited by this paper
• Gut microbiota protects against gastrointestinal tumorigenesis caused by epithelial injury.

  2013cited by this paper
• Dysbiosis Signature of Fecal Microbiota in Colorectal Cancer Patients

  2013cited by this paper
• Stool Microbiome and Metabolome Differences between Colorectal Cancer Patients and Healthy Adults

  2013cited by this paper
• Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment.

  2013cited by this paper
• Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin.

  2013cited by this paper
• The microbiome and cancer

  2013cited by this paper
• Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota

  2012cited by this paper
• Gut microbiota accelerate tumor growth via c-jun and STAT3 phosphorylation in APCMin/+ mice.

  2012cited by this paper
• Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth

  2012cited by this paper
• Comprehensive molecular characterization of human colon and rectal cancer

  2012cited by this paper
• Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers

  2011cited by this paper
• ClbP Is a Prototype of a Peptidase Subgroup Involved in Biosynthesis of Nonribosomal Peptides*

  2011cited by this paper
• Fusobacterium nucleatum Outer Membrane Proteins Fap2 and RadD Induce Cell Death in Human Lymphocytes

  2010cited by this paper
• Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas

  2010cited by this paper
• A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses

  2009cited by this paper
• APC and its modifiers in colon cancer.

  2009cited by this paper
• Induction of inflammatory bowel disease accelerates adenoma formation in Min +/- mice.

  2006cited by this paper
• Escherichia coli Induces DNA Double-Strand Breaks in Eukaryotic Cells

  2006cited by this paper
• Identification and Characterization of a Novel Adhesin Unique to Oral Fusobacteria

  2005cited by this paper
• The role of mutant Apc in the development of dysplasia and cancer in the mouse model of dextran sulfate sodium-induced colitis.

  2001cited by this paper
• One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products.

  2000cited by this paper
• Intestinal neoplasia in the ApcMin mouse: independence from the microbial and natural killer (beige locus) status.

  1997cited by this paper
• A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse.

  1990cited by this paper

• Indole Profiles Define Disease-Specific Virulence in Fusobacterium nucleatum Clinical Isolates

  2026cites this paper
• Candida albicans synergizes with Fusobacteriumnucleatum in colorectal cancer progression via the Flo9-RadD interaction.

  2026cites this paper
• Gut microbiota affects the progression of colorectal cancer under the intervention of exercise.

  2026cites this paper
• Antimicrobial and Cytoprotective Effects of Tea Extracts Against Escherichia coli-Producing Colibactin Toxin Infections

  2025cites this paper
• L-serine promotes pro-carcinogenic effects of colibactin-producing E. coli

  2025cites this paper
• De-coding the complex role of microbial metabolites in cancer.

  2025cites this paper
• The multipotential effect of microbiome in lung cancer development and progression.

  2025cites this paper
• The specificity and structure of DNA crosslinking by the gut bacterial genotoxin colibactin

  2025cites this paper
• A defined bacterial consortium and spatial transcriptomics highlight the complex interaction between Campylobacter jejuni and the murine intestine

  2025cites this paper
• Decoding the Tumor-Associated Microbiota: From Origins to Nanomedicine Applications in Cancer Therapy

  2025cites this paper
• Genomic characterization of Escherichia coli with a polyketide synthase (pks) island isolated from ulcerative colitis patients

  2025cites this paper
• Influence of bacterial proteins on the host’s cell cycle

  2025cites this paper
• A Review of Susceptibility Factors for Colibactin-Associated Colorectal Cancer in African Populations

  2025cites this paper
• Age-driven changes in the layer hen reproductive microbiome are associated with lay performance

  2025cites this paper
• Selection, Comparative Genomics, and Potential Probiotic Features of Escherichia coli 5C, a pks-Negative Strain Isolated from Healthy Infant Donor Feces.

  2025cites this paper
• Fusobacterium nucleatum is enriched in invasive biofilms in colorectal cancer

  2025cites this paper
• Surface expression of antitoxin on engineered bacteria neutralizes genotoxic colibactin in the gut

  2025cites this paper
• A genotoxin associated with colorectal cancer linked to gut dysbiosis in children with cystic fibrosis

  2025cites this paper
• Phenotypic characterization and complete genome of a tumorigenic pathobiont Escherichia coli LI60C3

  2025cites this paper
• Exploring novel strategies of oncolytic viruses and gut microbiota to enhance CAR-T cell therapy for colorectal cancer.

  2025cites this paper
• Microbial-derived immunostimulatory small molecule augments anti-PD-1 therapy in lung cancer

  2025cites this paper
• Fusobacterium nucleatum is enriched in invasive biofilms in colorectal cancer

  2025cites this paper
• Genetic Disruption of hnRNPI Reveals a Microbial-Metabolic Axis in Colitis-Associated Cancer.

  2025cites this paper
• The specificity and structure of DNA crosslinking by the gut bacterial genotoxin colibactin

  2025cites this paper
• Infectious Carcinogens Derived from Intestinal Microflora: Mechanisms of Microbial Transitions from Eubionts to Pathobionts.

  2025cites this paper
• Natural polysaccharides regulate intestinal microbiota for inhibiting colorectal cancer

  2024cites this paper
• Multi-kingdom microbial signatures in excess body weight colorectal cancer based on global metagenomic analysis

  2024cites this paper
• A distinct Fusobacterium nucleatum clade dominates the colorectal cancer niche

  2024cites this paper
• A guide to germ‐free and gnotobiotic mouse technology to study health and disease

  2024influential citation
• Targeting bacterial metabolites in tumor for cancer therapy: An alternative approach for targeting tumor-associated bacteria.

  2024cites this paper
• Gut microbiota and their derivatives in the progression of colorectal cancer: Mechanisms of action, genome and epigenome contributions

  2024cites this paper
• Microbiota-derived small molecule genotoxins: host interactions and ecological impact in the gut ecosystem

  2024cites this paper
• Colorectal cancer-associated bacteria are broadly distributed in global microbiomes and drivers of precancerous change

  2024influential citation
• Microbiota-associated mechanisms in colorectal cancer.

  2024cites this paper
• Progress of “Yiqi and Spleen Enhancement Method” in the Treatment of Colorectal Cancer based on Intestinal Flora

  2024cites this paper
• The synthesis of the novel Escherichia coli toxin—colibactin and its mechanisms of tumorigenesis of colorectal cancer

  2024cites this paper
• Colibactin-driven colon cancer requires adhesin-mediated epithelial binding

  2024cites this paper
• Biofilm-derived oxylipin 10-HOME–mediated immune response in women with breast implants

  2023cites this paper
• An Insight on Gut Flora, Colorectal Cancer Mechanism, and Treatment Strategies

  2023cites this paper
• Intracellular bacteria in cancer—prospects and debates

  2023cites this paper
• Gut Microbiota in Colorectal Cancer: Biological Role and Therapeutic Opportunities

  2023cites this paper
• The microbial landscape of colorectal cancer

  2023cites this paper
• Bacterial Oncotraits Rather than Spatial Organization Are Associated with Dysplasia in Ulcerative Colitis

  2023cites this paper
• Intestinal bacteria and colorectal cancer: etiology and treatment

  2023cites this paper
• Using gut microbiota as a diagnostic tool for colorectal cancer: machine learning techniques reveal promising results.

  2023cites this paper
• Role of the Gut Microbiota and Its Metabolites in Tumorigenesis or Development of Colorectal Cancer

  2023cites this paper
• Microbiome in Colonic Carcinogenesis.

  2023cites this paper
• Colibactin-induced genotoxicity and colorectal cancer exacerbation critically depends on adhesin-mediated epithelial binding

  2023cites this paper
• Molecular Pathways of Carcinogenesis in Familial Adenomatous Polyposis

  2023cites this paper
• Cytotoxic necrotizing factor 1 hinders colon tumorigenesis induced by colibactin-producing Escherichia coli in ApcMin/+ mice

  2023cites this paper
• Colorectal cancer–associated T cell receptor repertoire abnormalities are linked to gut microbiome shifts and somatic cell mutations

  2023cites this paper
• Role of Bacteria in the Development of Colorectal Cancer

  2023cites this paper
• Insights into vitamin A in bladder cancer, lack of attention to gut microbiota?

  2023cites this paper
• A small molecule inhibitor prevents gut bacterial genotoxin production

  2022cites this paper
• Commensal microbiota from patients with inflammatory bowel disease produce genotoxic metabolites

  2022cites this paper
• The impact of the human microbiome in tumorigenesis, cancer progression, and biotherapeutic development

  2022cites this paper
• Colorectal cancer: the facts in the case of the microbiota

  2022cites this paper
• Colibactin possessing E. coli isolates in association with colorectal cancer and their genetic diversity among Pakistani population

  2022cites this paper
• The Microbiome-Immune Axis Therapeutic Effects in Cancer Treatments

  2022cites this paper
• Tumor tissue-specific bacterial biomarker panel for colorectal cancer: Bacteroides massiliensis, Alistipes species, Alistipes onderdonkii, Bifidobacterium pseudocatenulatum, Corynebacterium appendicis

  2022cites this paper
• Fusobacterium and Colorectal Cancer: Important Association or Random Coincidence?

  2022cites this paper
• Sex-Dependent Differences in Colorectal Cancer: With a Focus on Obesity

  2022cites this paper
• Inhibition of gut microbial β-glucuronidase effectively prevents carcinogen-induced microbial dysbiosis and intestinal tumorigenesis.

  2022cites this paper
• The bacterial toxin colibactin triggers prophage induction

  2022cites this paper
• Antitumor effects of fecal microbiota transplantation: Implications for microbiome modulation in cancer treatment

  2022cites this paper
• Comparative Analysis of Colon Cancer-Derived Fusobacterium nucleatum Subspecies: Inflammation and Colon Tumorigenesis in Murine Models

  2022influential citation
• The Emerging Roles of Human Gut Microbiota in Gastrointestinal Cancer

  2022cites this paper
• Cancer as microenvironmental, systemic and environmental diseases: opportunity for transdisciplinary microbiomics science

  2022cites this paper
• Mouse Models for Application in Colorectal Cancer: Understanding the Pathogenesis and Relevance to the Human Condition

  2022cites this paper
• BACTERIAL ONCOTRAITS BUT NOT BIOFILMS ARE ASSOCIATED WITH DYSPLASIA IN ULCERATIVE COLITIS

  2022cites this paper
• The gut microbial metabolite formate exacerbates colorectal cancer progression

  2022cites this paper
• The Microbiome in Gastrointestinal Cancers.

  2022cites this paper
• The pks island: a bacterial Swiss army knife?: Colibactin: beyond DNA damage and cancer.

  2022cites this paper
• Immunomodulatory properties of CNF1 toxin from E. coli: implications for colorectal carcinogenesis.

  2022cites this paper
• Interaction of bacterial genera associated with therapeutic response to immune checkpoint PD-1 blockade in a United States cohort

  2022cites this paper
• Emerging strategies for engineering Escherichia coli Nissle 1917-based therapeutics.

  2022cites this paper
• A 3D‐printable device allowing fast and reproducible longitudinal preparation of mouse intestines

  2022cites this paper
• Emerging Tests for Noninvasive Colorectal Cancer Screening.

  2022cites this paper
• Implication of gut microbes and its metabolites in colorectal cancer

  2022cites this paper
• Comparing Transgenic Production to Supplementation of ω-3 PUFA Reveals Distinct But Overlapping Mechanisms Underlying Protection Against Metabolic and Hepatic Disorders

  2022cites this paper
• Determination of biomarkers associated with neoadjuvant treatment response focusing on colibactin-producing Escherichia coli in patients with mid or low rectal cancer: a prospective clinical study protocol (MICARE)

  2022cites this paper
• Inflammatory bowel disease and carcinogenesis

  2022cites this paper
• Decreased NHE3 expression in colon cancer is associated with DNA damage, increased inflammation and tumor growth

  2022cites this paper
• Fusobacterium nucleatum and colorectal cancer: From phenomenon to mechanism

  2022influential citation
• Die Rolle des Mikrobioms in der gastrointestinalen Karzinogenese

  2022cites this paper
• Multifaceted Impacts of Periodontal Pathogens in Disorders of the Intestinal Barrier

  2021cites this paper
• Metadata of the article that will be visualized in OnlineFirst

  2021cites this paper
• Genomic, Microbial and Immunological Microenvironment of Colorectal Polyps

  2021cites this paper
• Human Gut Microbiota in Health and Selected Cancers

  2021cites this paper
• Gut microbiota-derived short-chain fatty acids regulate IL-17 production by mouse and human intestinal γδ T cells.

  2021cites this paper
• Fusobacterium nucleatum Acts as a Pro-carcinogenic Bacterium in Colorectal Cancer: From Association to Causality

  2021cites this paper
• Role of Gut Microbiota and Probiotics in Colorectal Cancer: Onset and Progression

  2021cites this paper
• Gut Dysbiosis and Intestinal Barrier Dysfunction: Potential Explanation for Early-Onset Colorectal Cancer

  2021cites this paper
• Microbe-Based Therapies for Colorectal Cancer: Advantages and Limitations.

  2021cites this paper
• Modern Germ-Free Study Designs and Emerging Static Housing Technology in a Growing “Human Microbiome” Research Market

  2021cites this paper
• Tackling the Threat of Cancer Due to Pathobionts Producing Colibactin: Is Mesalamine the Magic Bullet?

  2021cites this paper
• Gut Microbiota as Potential Biomarker and/or Therapeutic Target to Improve the Management of Cancer: Focus on Colibactin-Producing Escherichia coli in Colorectal Cancer

  2021cites this paper
• It takes a village: microbiota, parainflammation, paligenosis and bystander effects in colorectal cancer initiation.

  2021cites this paper
• Evolution of Polymyxin Resistance Regulates Colibactin Production in Escherichia coli.

  2021cites this paper
• Structural Basis for the Interactions of the Colibactin Resistance Gene Product ClbS with DNA.

  2021cites this paper